Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1738 of 6351
-
Can a simple score shorten blood thinner use after a heart attack?
Disease control Recruiting nowMonotherapy with a P2Y12 inhibitor after a minimum period of DAPT following percutaneous coronary intervention (PCI) is an emerging de-escalation antiplatelet strategy in recent years. However, the optimal timing for de-escalating DAPT in ACS patients undergoing PCI remains debat…
Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:32 UTC
-
Can a 3D guide make sinus lifting for dental implants safer?
Disease control CompletedBackground: Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence lateral sinus lifting using surgical guide is …
Sponsor: Alexandria University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug aims to slow kidney damage in diabetes and rare diseases
Disease control Recruiting nowThis is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of WAL0921 in subjects with glomerular kidney disease and proteinuria, including diabetic nephropathy and rar…
Phase 2 • Sponsor: Walden Biosciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a common antidepressant supercharge lung cancer treatment?
Disease control Recruiting nowClinical Trial The objective of this clinical trial is to determine whether antidepressant medications, such as olanzapine, in combination with immune checkpoint inhibitors are more effective than the use of immune checkpoint inhibitors alone. The main questions it aims to answe…
Phase 2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Real-World data may reveal how acalabrutinib performs in chinese blood cancer patients
Knowledge-focused By invitation onlyThe primary purpose of this study is to describe acotinib treatment patterns in Chinese patients with CLL/SLL and MCL who received acotinib according to the label. Secondary objectives include: 1) To evaluate the safety of acotinib in Chinese patients with CLL/SLL and MCL who rec…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
New High-Tech glasses could help kids with low vision read better
Symptom relief CompletedThis clinical trial aims to assess the efficacy and safety of the Shilangqing Smart Reading Aid, a head-mounted device integrating XR and AI technologies, in improving reading performance and quality of life among children with low vision. The study employs a multicenter, randomi…
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Ancient needle technique may boost IVF success for hopeful moms
Symptom relief CompletedThis study aims to evaluate whether fire-needle combined with regular acupuncture improves pregnancy outcomes in patients with recurrent implantation failure (RIF), compared to no or regular acupuncture. A retrospective cohort study was conducted at a university-affiliated hospi…
Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Which anesthesia is safer for stroke surgery? new study aims to find out
Disease control Recruiting nowThe study is planned to evaluate the effectiveness and safety of two types of anesthesia (regional and general) for carotid endarterectomy in 100 patients with acute stage of stroke: 50 patients will be operated under regional anesthesia and the remaining 50 patients under genera…
Sponsor: Pirogov Russian National Research Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Brain fog breakthrough? simple supplement boosts memory in long COVID
Symptom relief CompletedAbstract Background: Post-COVID-19 cognitive impairment (PCCI), characterized by deficits in attention, memory, and executive functioning, remains a major challenge among patients with long COVID. Oxidative stress is a key contributor to this condition. Cysteine-rich whey protein…
Sponsor: Universidad Libre seccional Cali • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New model aims to treat opioid use disorder in mothers right at their baby's hospital bedside
Disease control Recruiting nowThe purpose of this study is to address the gap in maternal OUD treatment and infant neonatal opioid withdrawal syndrome care. The research team will develop a treatment model and a set of strategies to provide evidence-based OUD treatment to postpartum mothers in NICUs. First, …
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Brain training program aims to restore cognitive function in veterans with long COVID
Symptom relief By invitation onlyCognitive dysfunction, psychiatric symptoms, functional impairment, and disability following COVID-19 negatively impact Veterans' community functioning and quality of life, contribute to significant human suffering, and are costly to VHA. Rehabilitation is a critical priority for…
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can picking your own exercise pace ease fibromyalgia better than pushing hard?
Symptom relief CompletedThis randomized crossover clinical trial aims to verify and compare the effects of high-intensity (HIG) and preferred-intensity (PIG) resistance training on the health of women with fibromyalgia (FM). Secondary objectives include verifying differences after 4, 8, and 16 sessions,…
Sponsor: University of the State of Santa Catarina • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
A digital bridge: could an online pathway ease depression in cancer care?
Symptom relief OngoingThe purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment who report symptoms of depression.
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can an online program replace clinic visits for hearing aid users?
Symptom relief OngoingThe main questions the research aims to answer are short- and long-term effects on consequences of hearing loss depending on which type of follow-up the participant chooses.
Sponsor: Region Skane • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Sound waves vs. scope: a gentler way to spot pouch inflammation?
Diagnosis CompletedIntestinal ultrasound (IUS) has been studied in the evaluation of inflammatory bowel disease (IBD) and is increasingly used as a non-invasive, easy to use, cost-effective tool for point-of-care to assess disease activity and more recently to predict response to treatment. However…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Aug 14, 2026 00:00 UTC
-
New combo therapy aims to stop colorectal cancer from coming back
Disease control By invitation onlyEstablish the clinical technology system of routine adjuvant therapy combined with personalized immune regulation diagnosis and treatment technology for postoperative anti-relapse adjuvant therapy: Patients with MRD positive and high risk of recurrence after colorectal cancer sur…
Early phase 1 • Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Children's trial launches for Friedreich's ataxia drug
Disease control OngoingIn this study, researchers will learn more about BIIB141, also known as omaveloxolone or SKYCLARYS®. This drug has been approved, or made available for doctors to prescribe, for people with Friedrich's Ataxia (FA) who are at least 16 years old. But, it is not yet available for ch…
Phase 1 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo therapy aims to tackle tough lymphoma
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of Pembrolizumab in combination with Olaparib in participants with relapsed/refractory Peripheral T-cell Lymphoma (PTCL). The study mainly aims to evaluate: * objective response rate (ORR) as per Cheson resp…
Phase 2 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control
Last updated Jun 26, 2026 14:13 UTC
-
Light-Activated dye could save sight from severe eye infections
Disease control OngoingRose Bengal Electromagnetic Activation with Green light for Infection Reduction II (REAGIR II) is a randomized, double-masked feasibility study. The purpose of this study is to determine differences in 6-month visual acuity between medical antimicrobial treatments alone versus an…
Phase 3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New catheter offers hope for heart failure patients resistant to diuretics
Disease control CompletedThe study objective is to evaluate the feasibility of the Doraya Catheter and measure clinical performance and safety endpoints, in ADHF patients deemed to have insufficient diuretic response.
Sponsor: Revamp Medical Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC